Merck Outlines COVID-19 Vaccine And Antiviral Plans As Pandemic Dents Q2 Sales

 
• By Mandy Jackson

The expectation of a big second quarter sales decline proved true, but the situation is improving. Meanwhile, Merck & Co. is advancing two vaccines and an antiviral against the novel coronavirus. 

Q2
Merck & Co.'s Q2 revenue was down 8%; pharma revenue decreased 7% • Source: Shutterstock

More from Earnings

More from Business